Jun 2, 2025 | Blog, Neurological Disorders, News, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood
A six-year-old girl named Zara has become the first child in Australia to receive an infusion of her own stored cord blood as treatment for cerebral palsy outside of a clinical trial. Experts hope that this milestone will pave the way towards broader availability,...
Apr 25, 2025 | Blog, Neurological Disorders, News, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood
A review paper, newly published in the prestigious Pediatrics journal, statistically demonstrates that cord blood therapy for cerebral palsy is an effective treatment to improve the motor skills of children suffering from this condition. The paper is an analysis of...
Apr 9, 2025 | Blog, Blood Disorders, News, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood
A phase 1 trial of a novel cell therapy for lymphoma that is highly resistant to standard treatment (highly refractory lymphoma) has published very positive results in the Nature Medicine journal. The therapy, which uses natural killer (NK) cells derived from cord...
Mar 22, 2025 | Blog, News, Skeletal Diseases and Injuries, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood
Osteoarthritis, a chronic degenerative joint disease, affects millions of people worldwide and is a leading cause of disability.[1][2] Currently available treatments can offer relief from pain and other symptoms. However, they fail to address the root of the disease,...
Mar 7, 2025 | Blog, Neurological Disorders, News, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood, Uses for Cord Tissue
A new study on cell therapy for cerebral palsy has, for the first time, directly compared the efficacy of two different treatments. Although more research is needed, the study’s results offer valuable insights for future clinical trials tackling this challenging...
Feb 17, 2025 | Blog, Blood Disorders, News, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood
A CAR-T cell therapy for acute lymphoblastic leukaemia[1] has recently been approved by the FDA for use in clinical trials in the United States. The therapy is based on cells derived from allogeneic (donor) umbilical cord blood; it is the very first such treatment to...
First Cord Blood Treatment for Cerebral Palsy Performed in Australia
Could Cord Tissue Stem Cells Help Manage Type 2 Diabetes?
Early Insights Into Placenta Stem Cell Therapy for Multiple Sclerosis
Study Shows Improvement From Placenta Stem Cell Injections for Knee Osteoarthritis
Cord Tissue Stem Cell Therapy for Epidermolysis Bullosa Delivers Encouraging Outcomes
